Martin Jakob Larsen
Overview
Explore the profile of Martin Jakob Larsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kroigard A, Frost M, Larsen M, Ousager L, Frederiksen A
Bone
. 2016 Sep;
92:145-149.
PMID: 27591150
Microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1), or Taybi-Linder syndrome is characterized by distinctive skeletal dysplasia, severe intrauterine and postnatal growth retardation, microcephaly, dysmorphic features, and neurological malformations. It is...
12.
Khandige S, Asferg C, Rasmussen K, Larsen M, Overgaard M, Andersen T, et al.
mBio
. 2016 Aug;
7(4).
PMID: 27486187
Unlabelled: The ability to change cell morphology is an advantageous characteristic adopted by multiple pathogenic bacteria in order to evade host immune detection and assault during infection. Uropathogenic Escherichia coli...
13.
Kroigard A, Larsen M, Thomassen M, Kruse T
Breast J
. 2016 Apr;
22(4):420-30.
PMID: 27089067
Clinical management of breast cancer is increasingly personalized and based on molecular profiling. Often, primary tumors are used as proxies for systemic disease at the time of recurrence. However, recent...
14.
Kroigard A, Thomassen M, Laenkholm A, Kruse T, Larsen M
PLoS One
. 2016 Mar;
11(3):e0151664.
PMID: 27002637
Next generation sequencing is extensively applied to catalogue somatic mutations in cancer, in research settings and increasingly in clinical settings for molecular diagnostics, guiding therapy decisions. Somatic variant callers perform...
15.
Torring P, Larsen M, Kjeldsen A, Ousager L, Tan Q, Brusgaard K
Microvasc Res
. 2015 Apr;
99:118-26.
PMID: 25892364
Unlabelled: Hereditary hemorrhagic telangiectasia (HHT), the most common inherited vascular disorder, is predominantly caused by mutations in ENG and ACVRL1, which are part of the transforming growth factor beta (TGF-β)...
16.
Kroigard A, Larsen M, Laenkholm A, Knoop A, Jensen J, Bak M, et al.
Oncotarget
. 2015 Mar;
6(8):5634-49.
PMID: 25730902
Evolution of the breast cancer genome from pre-invasive stages to asynchronous metastasis is complex and mostly unexplored, but highly demanded as it may provide novel markers for and mechanistic insights...
17.
Nielsen C, Jakobsen M, Larsen M, Muller A, Hansen S, Lillevang S, et al.
J Clin Immunol
. 2014 Sep;
34(8):916-21.
PMID: 25216719
We report an infant of consanguineous parents of Turkish decent with a novel immunodeficiency associated with homozygosity for a nonsense mutation of the gene encoding Inhibitor of nuclear factor kappa-B...
18.
Torring P, Larsen M, Kjeldsen A, Ousager L, Tan Q, Brusgaard K
PLoS One
. 2014 Mar;
9(3):e90272.
PMID: 24603890
Hereditary Haemorrhagic Telangiectasia (HHT) is an autosomal dominantly inherited vascular disease characterized by the presence of mucocutaneous telangiectasia and arteriovenous malformations in visceral organs. HHT is predominantly caused by mutations...